Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Ordinary Shares, par value CHF 0.05 per share
-
Shares outstanding
-
66,413,214
-
Total 13F shares
-
18,789,459
-
Share change
-
+17,059,718
-
Total reported value
-
$331,458,776
-
Price per share
-
$17.53
-
Number of holders
-
29
-
Value change
-
+$301,136,000
-
Number of buys
-
27
Institutional Holders of SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) as of Q3 2021
As of 30 Sep 2021 SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) had 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 18,789,459 shares of stock of the company.
Largest 10 holders included GENERATION INVESTMENT MANAGEMENT LLP, PRICE T ROWE ASSOCIATES INC /MD/, PFM Health Sciences, LP, CREDIT SUISSE AG/, GENERAL ELECTRIC CO, PRINCIPAL FINANCIAL GROUP INC, JENNISON ASSOCIATES LLC, PICTET ASSET MANAGEMENT SA, PURA VIDA INVESTMENTS, LLC, and MILLENNIUM MANAGEMENT LLC.
This table shows 29 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.